Keyword
Quick search:
Result Content Outlet Published Research
Result Content Outlet Published Research
1 Should You Invest in Invitae Right Now? The Motley Fool 24 days ago
2 Invitae Corporation (NVTA) CEO Sean George on JPMorgan 40th Annual Healthcare Conference (Transcript) Seeking Alpha 5 days ago
3 Invitae Co. (NYSE:NVTA) Expected to Announce Earnings of -$0.74 Per Share MarketBeat 1 day ago
4 Invitae to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference The Bakersfield Californian 13 days ago
5 Zacks: Analysts Anticipate Invitae Co. (NYSE:NVTA) Will Post Quarterly Sales of $127.60 Million MarketBeat 20 days ago
6 How a Genetic Test Gave Me a Sense of Empowerment GoodHousekeeping.com 28 days ago
7 What Every Mom-To-Be Should Know About Prenatal Screenings Women's Health 28 days ago
8 Myriad Genetics Stock vs. Invitae Stock Nanalyze 2 months ago
9 360Dx Index Grows 4 Percent in December Alongside Broader Markets 360Dx 15 days ago
10 Fulgent Genetics, Bio-Techne Lead Winners as GenomeWeb Index Gains 12 Percent in 2021 GenomeWeb 14 days ago
11 Invitae scoops up consumer health tech firm Ciitizen for $325M FierceHealthcare 4 months ago
12 Exact Sciences Said to Approach Invitae About Merger Bloomberg 6 months ago
13 3 Things About Invitae That Smart Investors Should Know Motley Fool 6 months ago
14 Invitae Writes off $262.5M Liability Upon Failure to Meet Regulatory Milestone GenomeWeb 5 months ago
15 Antibodies, Easy Single-Cell, Genomics for All: Notes from the JP Morgan Healthcare Conference Bio-IT World 5 days ago
16 Outcomes4Me Partners with Invitae to Offer Genetic Testing to Breast Cancer Patients Business Wire 3 months ago
17 Invitae: New Low On Major Revenue Disappointment Seeking Alpha 2 months ago
18 Invitae's double deal day: A genomics buyout and $1.2B in SoftBank-led financing FierceBiotech 10 months ago
19 Cathie Wood Top Stock Picks Techstory 24 days ago
20 Why Invitae's Genomic Solution Will Drive Shares Higher Seeking Alpha 3 months ago
21 Northwestern University and Invitae Present New Research Highlighting the Importance of Genetic Testing for Cardiovascular Conditions at the American Heart Association Scientific Sessions PRNewswire 2 months ago
22 Invitae to Announce Third Quarter 2021 Financial Results on Monday, November 8, 2021 Yahoo Finance 3 months ago
23 Why Did Invitae Stock Fall 17% in July? Motley Fool 6 months ago
24 Can Invitae Be the Winner-Take-Most in Genetic Testing? Motley Fool 8 months ago
25 Is Invitae a Buy? | The Motley Fool The Motley Fool 9 months ago
26 “I'm a Doctor—Here's How I'm Staying Healthy Over 40” Oprah Mag 28 days ago
27 Why Invitae Was Down 17.5% in May | The Motley Fool The Motley Fool 7 months ago
28 Volpara Collaborates with Invitae Corporation for Genetic Testing Services Imaging Technology News 6 months ago
29 Invitae borrows against the future Vantage 10 months ago
30 Cathie Wood called this one of her most underappreciated stocks. Its CEO explains its growth story CNBC 10 months ago
31 The Stitch in Morrisville will house the Invitae facility, 374 jobs WRAL Tech Wire 9 months ago
32 Invitae Sues Natera Over Alleged Infringement of Sequence Assembly Patents GenomeWeb 2 months ago
33 Why Invitae Stock Is Climbing Today Motley Fool 6 months ago
34 Invitae Sues Natera Alleging Infringement of Patent on DNA Sequencing Assembly Technique GenomeWeb 8 months ago
35 Invitae joins NIH-sponsored study aimed at improving understanding of the links between genes and cancer, heart disease and other conditions PRNewswire 10 months ago
36 Making Sense Of The Possible Merger Between Exact Sciences And Invitae Seeking Alpha 5 months ago
37 Cancer Stocks Exact Sciences and Invitae Are Sliding. Here's Why. Barron's 9 months ago
38 Invitae (NVTA) to Report Q1 Earnings: What's in the Offing? Yahoo Finance 9 months ago
39 Should You Buy Invitae Stock? The Motley Fool 11 months ago
40 Pacific Biosciences and Invitae Announce Intent to Expand Collaboration Yahoo Finance 6 months ago
41 Invitae opens early access to liquid biopsy-based Personalized Cancer Monitoring as a central laboratory service BioSpace 8 months ago
42 Invitae to Present at the Morgan Stanley 19th Annual Global Healthcare Conference PRNewswire 5 months ago
43 Invitae, UCL and the Francis Crick Institute Announce New Data From TRACERx Research Collaboration at the 2021 International Society of Liquid Biopsy Congress PRNewswire 3 months ago
44 Beckman Coulter, Invitae Partner to Develop NGS Library Prep Applications GenomeWeb 4 months ago
45 Invitae Stock – A Pure-Play on Genetics Testing Nanalyze 2 years ago
46 Invitae appoints technology and medtech veteran Roxi Wen as chief financial officer PRNewswire 7 months ago
47 Hedge Funds Are Cashing Out Of InVitae Corporation (NVTA) Yahoo Finance 3 months ago
48 What Type Of Shareholders Make Up Invitae Corporation's (NYSE:NVTA) Share Registry? Yahoo Finance 3 months ago
49 Star Stockpicker Cathie Wood Dismisses Hyper Inflation Risk And Pitches Zoom And Invitae During Forbes’ 2021 Wealth Summit Forbes 3 months ago
50 How Do Fulgent Genetics and Invitae Stack Up Against Each Other? Motley Fool 10 months ago
51 Invitae Launches Free Genetic Testing for At-risk Adults Parkinson's News Today 10 months ago
52 Investors push Invitae (NYSE:NVTA) 4.7% lower this week, company's increasing losses might be to blame Nasdaq 4 months ago
53 Cooper announces genetic testing company to create 374 jobs in Wake County WTVD-TV 9 months ago
54 Best Places to Work 2021: Invitae keeps a focus on the core elements of their culture amid changes San Francisco Business Times 9 months ago
55 Invitae, PCT Therapeutics, Genome Medical Partner to Offer Genetic Testing for Cerebral Palsy GenomeWeb 9 months ago
56 Invitae adds Medneon's risk assessment tools to its education and clinical support offerings PRNewswire 11 months ago
57 Oversold Conditions For Invitae (NVTA) Nasdaq 2 months ago
58 Invitae Corporation (NVTA) CEO Sean George Presents at William Blair 41st Annual Growth Stock Conference (Transcript) Seeking Alpha 8 months ago
59 Invitae Stock Is Estimated To Be Significantly Overvalued Yahoo Finance 7 months ago
60 New Study Highlights the Value of Genetic Testing to Guide Clinical Management and Improve Outcomes for Epilepsy Patients PRNewswire 4 months ago
61 Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform GlobeNewswire 1 year ago
62 Invitae Announces Pricing of Public Offering of Common Stock PRNewswire 12 months ago
63 Invitae: Revolutionizing Genetic Testing Seeking Alpha 1 year ago
64 Healthcare Dealmakers—Intermountain, SCL Health's 33-hospital merger; Invitae's $325M Ciitizen acquisition FierceHealthcare 3 months ago
65 Why Bionano Genomics, Invitae, and Opko Health Stocks Sank This Week Motley Fool 6 months ago
66 Could Invitae Be a Millionaire-Maker Stock? The Motley Fool 2 years ago
67 Invitae ends medtech merger drought with ArcherDX deal Vantage 2 years ago
68 EXCLUSIVE: Invitae CEO On Making Genetics Cost-Effective And Accessible Benzinga 8 months ago
69 First Week of March 2022 Options Trading For Invitae (NVTA) Nasdaq 2 months ago
70 Implied Volatility Surging for Invitae (NVTA) Stock Options Nasdaq 1 month ago
71 Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology PRNewswire 2 years ago
72 Pharming Group, in collaboration with Invitae Corporation, launches genetic testing program 'navigateAPDS' in US and Canada PRNewswire 11 months ago
73 Invitae: Network Strategy And Industry Tailwinds Should Offer Path To Profitability Seeking Alpha 1 year ago
74 Invitae Makes a Precision Oncology Push With $886M Deal for ArcherDx Xconomy 2 years ago
75 Hi, we're Invitae Built In Austin 1 year ago
76 Form 10-Q Invitae Corp For: Sep 30 StreetInsider.com 2 months ago
77 FDA Accepts Invitae Premarket Approval Submission for Stratafide Companion Diagnostic GenomeWeb 1 year ago
78 Invitae Genetics is rolling out personal genetic testing Business Insider 3 years ago
79 Invitae Completes Acquisition of ArcherDx Precision Oncology News 1 year ago
80 Decibel Therapeutics and Invitae Announce Launch of Amplify™ Genetic Testing Program Business Wire 12 months ago
81 Stocks making the biggest moves after the bell: Zoom Video, Stitch Fix, Invitae & more CNBC 11 months ago
82 Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML) BioSpace 1 year ago
83 Invitae and Pacific Biosciences Collaborate to Develop Whole Genome Sequencing-Based Assays for Pediatric Epilepsy Diagnostics GlobeNewswire 1 year ago
84 Better Buy: Invitae vs. Illumina Motley Fool 1 year ago
85 Invitae to Acquire Jungla to Advance Genetic Variant Interpretation, Adds Supplemental RNA Analysis to Deliver Deeper, More Informative Results to Patients BioSpace 3 years ago
86 JP Morgan Healthcare Conference 2021, Day 2: Qiagen, Invitae, Agilent, Sema4, More GenomeWeb 1 year ago
87 Top Five Articles on GenomeWeb Last Week: Singular Genomics, Invitae, COVID-19, and More GenomeWeb 8 months ago
88 Invitae to Acquire Singular Bio for $55M GenomeWeb 3 years ago
89 Storage For Fast Genomics And Risk Analysis Forbes 6 months ago
90 Invitae: Exponential Growth In Genetic Testing Seeking Alpha 2 years ago
91 Muhlenkamp’s Firm Buys Equity Commonwealth, Dumps 2 Stocks Forbes 1 month ago
92 Accelerate, Invitae Lead Gainers as 360Dx Index Ticks Up in June 360Dx 2 years ago
93 Transformed mall in Morrisville now fully leased with 375-job project (Gallery) Triangle Business Journal 9 months ago
94 Invitae launches enhanced capabilities to support telemedicine PRNewswire 2 years ago
95 ASB leases 40,000 sq ft at 444 De Haro to Invitae Property Funds World 11 months ago
96 Invitae to Present at the 39th Annual JP Morgan Healthcare Conference BioSpace 1 year ago
97 Invitae (NVTA) to Report Q3 Earnings: What's in the Cards? Yahoo Finance 1 year ago
98 Invitae Acquiring Jungla for up to $65M to Enhance Variant Interpretation GenomeWeb 3 years ago
99 Invitae Needs To Validate How It Really Intends To Make Money Seeking Alpha 2 years ago
100 How Natera Is Defending Its Lead in a $15B Cancer-Testing Market Barron's 7 months ago